Norges Bank Moderna, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $339 Million - $558 Million	3,350,793 New	3,350,793 $398 Million
Q4 2023 Feb 09, 2024	BUY	$69.51 - $104.43 $243 Million - $365 Million	3,494,874 New	3,494,874 $348 Million
Q3 2023 Nov 13, 2024	BUY	$96.41 - $126.61 $326 Million - $428 Million	3,377,794 New	3,377,794 $349 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $335 Million - $440 Million	-3,478,665 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$118.5 - $160.53 $98 Million - $133 Million	-826,939 Reduced 24.68%	2,523,854 $307 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $399 Million - $541 Million	-3,369,189 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$135.66 - $197.02 $434 Million - $631 Million	3,202,293 New	3,202,293 $492 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $414 Million - $735 Million	3,498,267 New	3,498,267 $628 Million
Q3 2022 Nov 13, 2023	BUY	$118.07 - $194.18 $411 Million - $675 Million	3,478,665 New	3,478,665 $411 Million
Q2 2022 Aug 14, 2023	BUY	$117.13 - $176.59 $395 Million - $595 Million	3,369,189 New	3,369,189 $481 Million
Q1 2022 May 12, 2023	SELL	$126.46 - $235.05 $57.7 Million - $107 Million	-456,087 Reduced 13.04%	3,042,180 $524 Million
Q1 2022 May 09, 2022	SELL	$126.46 - $235.05 $385 Million - $716 Million	-3,044,449 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$225.82 - $368.51 $687 Million - $1.12 Billion	3,044,449 New	3,044,449 $773 Million
Q3 2021 Nov 14, 2022	BUY	$221.9 - $484.47 $686 Million - $1.5 Billion	3,090,117 New	3,090,117 $1.19 Billion
Q3 2021 Nov 05, 2021	SELL	$221.9 - $484.47 $696 Million - $1.52 Billion	-3,135,597 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$129.91 - $234.98 $407 Million - $737 Million	3,135,597 New	3,135,597 $737 Million
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $310 Million - $561 Million	-2,387,985 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$109.18 - $185.98 $261 Million - $444 Million	2,387,985 New	2,387,985 $313 Million
Q1 2021 May 07, 2021	SELL	$109.18 - $185.98 $252 Million - $429 Million	-2,306,050 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$65.74 - $169.86 $152 Million - $392 Million	2,306,050 New	2,306,050 $241 Million
Q4 2020 Feb 10, 2021	SELL	$65.74 - $169.86 $137 Million - $354 Million	-2,083,343 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$54.34 - $94.85 $113 Million - $198 Million	2,083,343 New	2,083,343 $147 Million
Q3 2020 Nov 10, 2020	SELL	$54.34 - $94.85 $102 Million - $178 Million	-1,881,549 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$29.67 - $80.0 $55.8 Million - $151 Million	1,881,549 New	1,881,549 $121 Million
Q2 2020 Aug 07, 2020	SELL	$29.67 - $80.0 $68.4 Million - $184 Million	-2,304,942 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$17.78 - $31.58 $41 Million - $72.8 Million	2,304,942 New	2,304,942 $69 Million
Q1 2020 May 08, 2020	SELL	$17.78 - $31.58 $9.89 Million - $17.6 Million	-556,427 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$13.93 - $21.28 $7.75 Million - $11.8 Million	556,427 New	556,427 $10.9 Million
Q4 2019 Feb 12, 2020	SELL	$13.93 - $21.28 $11.3 Million - $17.2 Million	-808,438 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$12.26 - $18.07 $9.91 Million - $14.6 Million	808,438 New	808,438 $12.9 Million
Q3 2019 Nov 08, 2019	SELL	$12.26 - $18.07 $8.45 Million - $12.4 Million	-688,931 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$13.7 - $28.34 $9.44 Million - $19.5 Million	688,931 New	688,931 $10.1 Million
Q2 2019 Aug 09, 2019	SELL	$13.7 - $28.34 $11.3 Million - $23.4 Million	-825,000 Closed	0 $0
Q4 2018 Mar 04, 2019	BUY	$13.52 - $18.8 $11.2 Million - $15.5 Million	825,000 New	825,000 $12.6 Million

Others Institutions Holding MRNA

# of Institutions

940

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account